BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3167829)

  • 1. Metabolism and excretion of etoposide in isolated, perfused rat liver models.
    Hande K; Bennett R; Hamilton R; Grote T; Branch R
    Cancer Res; 1988 Oct; 48(20):5692-5. PubMed ID: 3167829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfobromophthalein metabolism in isolated perfused rat liver. Factors determining the applicability of the model.
    Céspedes JM; Rodríguez Garay EA
    Acta Physiol Lat Am; 1979; 29(4-5):207-15. PubMed ID: 263170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of etoposide elimination in the isolated perfused rat liver by Cremophor EL and Tween 80.
    Ellis AG; Crinis NA; Webster LK
    Cancer Chemother Pharmacol; 1996; 38(1):81-7. PubMed ID: 8603456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Periportal localization of lorazepam glucuronidation in the isolated perfused rat liver.
    Branch RA; Cotham R; Johnson R; Porter J; Desmond PV; Schenker S
    J Lab Clin Med; 1983 Nov; 102(5):805-12. PubMed ID: 6631171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered hepatic disposition of doxorubicin in the perfused rat liver at hyperthermic temperatures.
    Skibba JL; Jones FE; Condon RE
    Cancer Treat Rep; 1982 Jun; 66(6):1357-63. PubMed ID: 7083240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differential localization of various drug metabolizing systems within the rat liver lobule as determined by the hepatotoxins allyl alcohol, carbon tetrachloride and bromobenzene.
    James R; Desmond P; Küpfer A; Schenker S; Branch RA
    J Pharmacol Exp Ther; 1981 Apr; 217(1):127-32. PubMed ID: 7205647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The handling of bilirubin and sulfobromophthalein by the isolated perfused rat liver.
    Céspedes JM; Rodríguez Garay EA
    Acta Physiol Lat Am; 1979; 29(4-5):217-22. PubMed ID: 263171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered hepatobiliary disposition of acetaminophen metabolites after phenobarbital pretreatment and renal ligation: evidence for impaired biliary excretion and a diffusional barrier.
    Brouwer KL; Jones JA
    J Pharmacol Exp Ther; 1990 Feb; 252(2):657-64. PubMed ID: 2313593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced hepatic clearance of propranolol induced by chronic carbon tetrachloride treatment in rats.
    Iwamoto K; Watanabe J; Araki K; Satoh M; Deguchi N
    J Pharmacol Exp Ther; 1985 Aug; 234(2):470-5. PubMed ID: 4020680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in pentobarbital and meperidine pharmacokinetics induced by bile duct ligation in the rat.
    Knodell RG; Brooks DA; Allen RC; Kyner WT
    J Pharmacol Exp Ther; 1980 Dec; 215(3):619-25. PubMed ID: 7441521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclosporine A on the hepatobiliary disposition and hepatic uptake of etoposide in an isolated perfused rat liver model.
    Khezrian M; Sheikholeslami B; Dadashzadeh S; Lavasani H; Rouini M
    Cancer Chemother Pharmacol; 2015 May; 75(5):961-8. PubMed ID: 25757960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of 14C-griseofulvin metabolism in rat liver microsomes, isolated perfused rat livers, and in rats with bile duct cannulas.
    Chang RL; Zampaglione N; Lin C
    Drug Metab Dispos; 1975; 3(6):487-93. PubMed ID: 1223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of colchicine-specific Fab fragments on the hepatic clearance of colchicine.
    Sabouraud A; Redureau M; Gires P; Martinet M; Scherrmann JM
    Drug Metab Dispos; 1993; 21(6):997-1002. PubMed ID: 7905405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic disposition of the acyl glucuronide 1-O-gemfibrozil-beta-D-glucuronide: effects of clofibric acid, acetaminophen, and acetaminophen glucuronide.
    Sabordo L; Sallustio BC; Evans AM; Nation RL
    J Pharmacol Exp Ther; 2000 Oct; 295(1):44-50. PubMed ID: 10991959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure of rats to inhalational anesthetics alters the hepatobiliary clearance of cholephilic xenobiotics.
    Watkins JB
    J Pharmacol Exp Ther; 1989 Aug; 250(2):421-7. PubMed ID: 2760837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide kinetics in patients with obstructive jaundice.
    Hande KR; Wolff SN; Greco FA; Hainsworth JD; Reed G; Johnson DH
    J Clin Oncol; 1990 Jun; 8(6):1101-7. PubMed ID: 2348225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired biliary excretion of taurocholate associated with increased biliary tree permeability in mirex- or chlordecone-pretreated rats.
    Curtis LR; Hoyt D
    J Pharmacol Exp Ther; 1984 Dec; 231(3):495-501. PubMed ID: 6209385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypan blue uptake as a new method to investigate hepatotoxicity in periportal and pericentral regions of the liver lobule: studies with allyl alcohol in the perfused liver.
    Belinsky SA; Popp JA; Kauffman FC; Thurman RG
    J Pharmacol Exp Ther; 1984 Sep; 230(3):755-60. PubMed ID: 6470978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of blockage of urine and/or bile flow on diflunisal conjugation and disposition in rats.
    Watt JA; Dickinson RG
    Xenobiotica; 1990 Aug; 20(8):835-45. PubMed ID: 2219966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary excretion of etoposide in children with cancer.
    Veal GJ; Errington J; Thomas HD; Boddy AV; Lowis S
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):415-7. PubMed ID: 16418874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.